Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease

Diabetologia

Volumn 53, Issue 2, 2010, Pages 277-280

  Nathanson, D ^a   Zethelius, B ^b   Berne, C ^c   Holst, J J ^d   Sjoholm A ^a   Nystrom T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Coronary heart disease; Glucagon like peptide 1; Impaired glucose tolerance; Type 2 diabetes

Indexed keywords

ALBUMIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LIPID;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FOLLOW UP; GERIATRICS; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECRETION; WAIST CIRCUMFERENCE;

AGED; ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FASTING; FOLLOW-UP STUDIES; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; SURVIVAL ANALYSIS; WAIST CIRCUMFERENCE;

EID: 77949287808     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1596-0     Document Type: Article

References (9)

1. Nyström T (2008) The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance. Horm Metab Res 40:593-606
2. Toft-Nielsen MB, Damholt MB, Madsbad S et al (2001) Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723 (Pubitemid 32755966)
3. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2002) Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153-2158
4. Nyström T, Gutniak MK, Zhang Q et al (2004) Effects of glucagonlike peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol 287:E1209-E1215
5. Byberg L, McKeigue PM, Zethelius B, Lithell HO (2000) Birth weight and the insulin resistance syndrome: association of low birth weight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or plasma lipid disturbances. Diabetologia 43:54-60
6. Merlo J, Lindblad U, Pessah-Rasmussen H et al (2000) Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16:235-243
7. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
8. Prigeon RL, Quddusi S, Paty B, D'Alessio DA (2003) Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect. Am J Physiol 285:E701-E707
9. Mannucci E, Ognibene A, Cremasco F et al (2001) Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. Diabetes Care 24:489-494